While life expectancies are approaching the national norm among white, affluent gay men, about 66 percent of the 1.2 million people living with HIV/AIDS in the United States are not in treatment.
By Barbara Feder Ostrov, Kaiser Health News
Prudential Financial Inc., one of the nation’s largest life insurers, plans to announce this week that it will offer traditional individual policies to eligible people living with HIV.
By PBS NewsHour
NewsHour's John Carlos Frey reports in this updated segment on San Francisco's plan to zero out the number of new HIV infections. The city's public health officials, doctors, and activists have made huge strides battling the epidemic and are now…
By Colleen Shalby
In revealing his HIV-positive status, actor Charlie Sheen said that he had unprotected sex with some sexual partners after his diagnosis, but had done so safely to ensure that none would contract HIV. Learn more about what he meant.
By Associated Press
After actor Charlie Sheen revealed on today's "Today Show" that he has been HIV-positive for four years, news spread across the Internet. Here are some facts about HIV, from the Centers for Disease Control and Prevention.
More than 30 years after she identified one of the most pernicious viruses to infect humankind, Françoise Barré-Sinoussi, who shared the Nobel Prize in Physiology or Medicine for discovering HIV, is retiring. Barré-Sinoussi says even though a cure may never…
By Larisa Epatko
Khanyisile Mavimbela was five months pregnant in 2008 when she took a test and learned she had HIV. She turned to a Mentor Mother for help and advice.
By Gretchen Frazee
The World Health Organization is recommending anyone infected with HIV begin treatment as soon as possible after diagnosis, making an additional nine million people eligible for treatment.
By Julie Pace, Associated Press
The Obama administration is announcing a $300 million program to drastically reduce HIV infections in girls and young woman in 10 sub-Saharan African nations hard hit by the virus.
By Michelle Harven
After outrage from the public and even presidential candidates, Turing Pharmaceuticals has announced it will reduce the price of the drug whose cost had previously increased by more than 5,000 percent practically overnight.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.